199 related articles for article (PubMed ID: 15944279)
1. Recombinant tumor-associated MUC1 glycoprotein impairs the differentiation and function of dendritic cells.
Rughetti A; Pellicciotta I; Biffoni M; Bäckström M; Link T; Bennet EP; Clausen H; Noll T; Hansson GC; Burchell JM; Frati L; Taylor-Papadimitriou J; Nuti M
J Immunol; 2005 Jun; 174(12):7764-72. PubMed ID: 15944279
[TBL] [Abstract][Full Text] [Related]
2. Human tumor antigen MUC1 is chemotactic for immature dendritic cells and elicits maturation but does not promote Th1 type immunity.
Carlos CA; Dong HF; Howard OM; Oppenheim JJ; Hanisch FG; Finn OJ
J Immunol; 2005 Aug; 175(3):1628-35. PubMed ID: 16034102
[TBL] [Abstract][Full Text] [Related]
3. Transduction of human dendritic cells with a recombinant modified vaccinia Ankara virus encoding MUC1 and IL-2.
Trevor KT; Hersh EM; Brailey J; Balloul JM; Acres B
Cancer Immunol Immunother; 2001 Oct; 50(8):397-407. PubMed ID: 11726134
[TBL] [Abstract][Full Text] [Related]
4. Transmembrane and secreted MUC1 probes show trafficking-dependent changes in O-glycan core profiles.
Engelmann K; Kinlough CL; Müller S; Razawi H; Baldus SE; Hughey RP; Hanisch FG
Glycobiology; 2005 Nov; 15(11):1111-24. PubMed ID: 15972891
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-Mediated MUC1 gene transduction into human blood-derived dendritic cells.
Maruyama K; Akiyama Y; Nara-Ashizawa N; Hojo T; Cheng JY; Mizuguchi H; Hayakawa T; Yamaguchi K
J Immunother; 2001; 24(4):345-53. PubMed ID: 11565836
[TBL] [Abstract][Full Text] [Related]
6. The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma.
Saeland E; van Vliet SJ; Bäckström M; van den Berg VC; Geijtenbeek TB; Meijer GA; van Kooyk Y
Cancer Immunol Immunother; 2007 Aug; 56(8):1225-36. PubMed ID: 17195076
[TBL] [Abstract][Full Text] [Related]
7. Expression of aberrantly glycosylated tumor mucin-1 on human DC after transduction with a fiber-modified adenoviral vector.
van Leeuwen EB; Cloosen S; Senden-Gijsbers BL; Agervig Tarp M; Mandel U; Clausen H; Havenga MJ; Duffour MT; García-Vallejo JJ; Germeraad WT; Bos GM
Cytotherapy; 2006; 8(1):24-35. PubMed ID: 16627342
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoids affect human dendritic cell differentiation and maturation.
Piemonti L; Monti P; Allavena P; Sironi M; Soldini L; Leone BE; Socci C; Di Carlo V
J Immunol; 1999 Jun; 162(11):6473-81. PubMed ID: 10352262
[TBL] [Abstract][Full Text] [Related]
9. Enhanced induction of anti-tumor CTLs in vitro by a lentivirus-transduced dendritic cell vaccine expressing secondary lymphoid tissue chemokine and mucin 1.
Wang B; Zhu Y; Zhang JJ; Chen Z; Liang WB; Xu ZK
Asian Pac J Cancer Prev; 2011; 12(11):2811-7. PubMed ID: 22393946
[TBL] [Abstract][Full Text] [Related]
10. Immune complexes inhibit differentiation, maturation, and function of human monocyte-derived dendritic cells.
Laborde EA; Vanzulli S; Beigier-Bompadre M; Isturiz MA; Ruggiero RA; Fourcade MG; Catalan Pellet AC; Sozzani S; Vulcano M
J Immunol; 2007 Jul; 179(1):673-81. PubMed ID: 17579090
[TBL] [Abstract][Full Text] [Related]
11. IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities.
Mohty M; Vialle-Castellano A; Nunes JA; Isnardon D; Olive D; Gaugler B
J Immunol; 2003 Oct; 171(7):3385-93. PubMed ID: 14500632
[TBL] [Abstract][Full Text] [Related]
12. Recombinant MUC1 mucin with a breast cancer-like O-glycosylation produced in large amounts in Chinese-hamster ovary cells.
Bäckström M; Link T; Olson FJ; Karlsson H; Graham R; Picco G; Burchell J; Taylor-Papadimitriou J; Noll T; Hansson GC
Biochem J; 2003 Dec; 376(Pt 3):677-86. PubMed ID: 12950230
[TBL] [Abstract][Full Text] [Related]
13. Human dendritic cells very efficiently present a heterologous antigen expressed on the surface of recombinant gram-positive bacteria to CD4+ T lymphocytes.
Corinti S; Medaglini D; Cavani A; Rescigno M; Pozzi G; Ricciardi-Castagnoli P; Girolomoni G
J Immunol; 1999 Sep; 163(6):3029-36. PubMed ID: 10477566
[TBL] [Abstract][Full Text] [Related]
14. Novel and detrimental effects of lipopolysaccharide on in vitro generation of immature dendritic cells: involvement of mitogen-activated protein kinase p38.
Xie J; Qian J; Wang S; Freeman ME; Epstein J; Yi Q
J Immunol; 2003 Nov; 171(9):4792-800. PubMed ID: 14568957
[TBL] [Abstract][Full Text] [Related]
15. Extracellular ATP induces a distorted maturation of dendritic cells and inhibits their capacity to initiate Th1 responses.
la Sala A; Ferrari D; Corinti S; Cavani A; Di Virgilio F; Girolomoni G
J Immunol; 2001 Feb; 166(3):1611-7. PubMed ID: 11160202
[TBL] [Abstract][Full Text] [Related]
16. Monocyte chemoattractant protein-1 selectively inhibits the acquisition of CD40 ligand-dependent IL-12-producing capacity of monocyte-derived dendritic cells and modulates Th1 immune response.
Omata N; Yasutomi M; Yamada A; Iwasaki H; Mayumi M; Ohshima Y
J Immunol; 2002 Nov; 169(9):4861-6. PubMed ID: 12391196
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of unresponsiveness to circulating tumor antigen MUC1 is a block in intracellular sorting and processing by dendritic cells.
Hiltbold EM; Vlad AM; Ciborowski P; Watkins SC; Finn OJ
J Immunol; 2000 Oct; 165(7):3730-41. PubMed ID: 11034378
[TBL] [Abstract][Full Text] [Related]
18. Monocyte-derived CD1a+ and CD1a- dendritic cell subsets differ in their cytokine production profiles, susceptibilities to transfection, and capacities to direct Th cell differentiation.
Chang CC; Wright A; Punnonen J
J Immunol; 2000 Oct; 165(7):3584-91. PubMed ID: 11034359
[TBL] [Abstract][Full Text] [Related]
19. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met inhibits human monocyte-derived dendritic cell maturation via formyl peptide receptor and formyl peptide receptor-like 2.
Kang HK; Lee HY; Kim MK; Park KS; Park YM; Kwak JY; Bae YS
J Immunol; 2005 Jul; 175(2):685-92. PubMed ID: 16002663
[TBL] [Abstract][Full Text] [Related]
20. Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors.
Dauer M; Obermaier B; Herten J; Haerle C; Pohl K; Rothenfusser S; Schnurr M; Endres S; Eigler A
J Immunol; 2003 Apr; 170(8):4069-76. PubMed ID: 12682236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
